NEW YORK (GenomeWeb News) – Agilent Technologies and Molecular Discovery on Sunday announced a co-marketing agreement to provide an advanced metabolite identification platform to biopharmaceutical researchers.

Under the terms of the deal, Agilent's high-resolution liquid chromatography/mass spectrometry technology will be co-marketed with Molecular Discovery's Mass-MetaSite software "to enable superior identification and analysis of complex biological mixtures," the firms said in a joint statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.